Clinical Trials · NCT04972721
SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 3,439
- Start date
- Sep 2023
- Locations
- 38 sites, 24 countries
- Primary endpoint
- Time to all-cause death